Next Generation Sequencing (NGS) in Agrigenomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Next Generation Sequencing (NGS) in Agrigenomics Market is projected to expand from a valuation of USD 2.99 Billion in 2025 to USD 4.56 Billion by 2031, registering a CAGR of 7.29%. NGS within this sector involves the utilization of high-throughput DNA sequencing to study the genomes of livestock and crops, aiming to bolster agricultural resilience and productivity. The market is primarily propelled by the rising global demand for food security, the urgent requirement for climate-adaptive crop varieties, and the decrease in sequencing costs which supports the widespread use of genomic selection. This reliance on advanced genetics is mirrored in industry optimism; the International Seed Federation noted in 2024 that over 90 percent of seed sector experts anticipate impending breeding breakthroughs will hasten the development of superior crop varieties.

Despite these growth drivers, the market encounters significant hurdles due to inconsistent and rigid regulatory frameworks concerning gene-edited products and the usage of genomic data. Divergent international policies can postpone the commercial launch of improved varieties and inflate compliance expenditures, creating obstacles for smaller entities. Furthermore, the immense volume of data produced by modern sequencing systems generates a bioinformatics bottleneck, necessitating specialized expertise and sophisticated computational infrastructure that restricts the speed at which some market participants can scale their operations.

Market Drivers

A primary engine for the Global Next Generation Sequencing (NGS) in Agrigenomics Market is the increase in government funding for agricultural biotechnology, which provides the necessary capital to mitigate risks associated with genomic tool development. Such public investment empowers institutions to undertake extensive sequencing projects, particularly in biodiversity and animal health, that private enterprises might view as too speculative. This financial backing supports advanced breeding programs focused on pathogen detection and trait improvement. For example, the USDA National Institute of Food and Agriculture invested $2.8 million in January 2026 into research projects centered on animal genomics and breeding, thereby advancing scientific knowledge and subsidizing infrastructure costs to lower entry barriers.

Concurrently, technological advancements in high-throughput sequencing platforms are driving market expansion by facilitating the rapid analysis of complex genomes essential for sustainable food production. Major corporations are committing significant resources to integrate genomic data with digital farming solutions to enhance crop resilience against climate change. To illustrate this commitment, Bayer reported in February 2025 that its Crop Science division invested €2.6 billion in Research and Development during the 2024 fiscal year. This corporate momentum is bolstered by a maturing regulatory environment; according to Euroseeds, by January 2025, nearly 300 regulatory decisions globally had confirmed the conventional status of plants derived from New Genomic Techniques by the end of 2024, creating an ecosystem ripe for commercial scaling.

Market Challenges

The expansion of the Global Next Generation Sequencing (NGS) in Agrigenomics Market is significantly hampered by rigid and inconsistent regulatory frameworks that create substantial barriers to commercializing genomic innovations. Although NGS technologies expedite the identification of beneficial traits, the subsequent development of gene-edited crops is often stalled by complex and divergent approval processes across different jurisdictions. These regulatory hurdles necessitate extensive and costly safety assessments, which can neutralize the financial benefits gained from reduced sequencing costs. Consequently, companies face prolonged timelines to bring improved varieties to market, which directly impacts their return on investment and slows the deployment of climate-resilient crops.

This regulatory uncertainty acts as a major deterrent to market growth. Data from the International Seed Federation in 2024 indicates that approximately one-third of the global seed sector views the implementation of predictable and science-based regulations as the most critical factor for unlocking further innovation. This struggle with a patchwork of international policies delays product introductions and places a disproportionate burden on smaller entities. By compelling market participants to allocate significant capital toward regulatory compliance rather than research, these frameworks effectively limit the market's potential for scalability and dynamism.

Market Trends

The sector is witnessing a transformative shift with the widespread adoption of third-generation long-read sequencing, which resolves the assembly limitations inherent in short-read technologies. Agrigenomic researchers are increasingly deploying these platforms to decode structural variants and highly repetitive regions in polyploid crops like sugarcane and wheat, facilitating the creation of gap-free, platinum-quality reference genomes needed for trait discovery. This surge in high-fidelity application is reflected in financial performance; Pacific Biosciences reported in their 'Third Quarter 2025 Financial Results' in November 2025 that record consumable revenue of $21.3 million was driven by the sustained demand for their long-read sequencing systems.

In parallel, the proliferation of low-coverage whole genome sequencing for high-throughput genotyping is displacing traditional microarray-based screening in large-scale breeding programs. This approach allows organizations to characterize vast mapping populations and germplasm banks by sequencing at lower depths and using imputation algorithms to infer missing genotypes, thereby drastically reducing the cost per data point. This trend illustrates a new era of industrial genomics scalability; according to Oxford Nanopore Technologies in a March 2025 presentation, novel workflows now enable the simultaneous sequencing of up to 100,000 samples at a cost of approximately one cent per specimen, significantly broadening the potential for biodiversity and trait analysis.

Key Players Profiled in the Next Generation Sequencing (NGS) in Agrigenomics Market

• 10x Genomics, Inc.
• Agrigenomics Inc.
• Daicel Arbor Biosciences
• Biogenetic Services Inc.
• Eurofins Scientific SE
• GALSEQ S.r.l.
• Illumina, Inc.
• Genome Life Sciences Private Limited
• NuGen Technologies Inc.

Report Scope

In this report, the Global Next Generation Sequencing (NGS) in Agrigenomics Market has been segmented into the following categories:

Next Generation Sequencing (NGS) in Agrigenomics Market, by Product:

• Kits & Consumables
• Instruments
• Others

Next Generation Sequencing (NGS) in Agrigenomics Market, by Technique:

• DNA Extraction & Purification
• DNA/RNA Sequencing
• Genotyping
• Marker Assistance Selection
• Others

Next Generation Sequencing (NGS) in Agrigenomics Market, by Application:

• Crops and Livestock

Next Generation Sequencing (NGS) in Agrigenomics Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing (NGS) in Agrigenomics Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.